IFS therapy
Selected indexed studies
- Moving from acceptance toward transformation with Internal Family Systems Therapy (IFS). (J Clin Psychol, 2013) [PMID:23813465]
- Emapalumab therapy for hemophagocytic lymphohistiocytosis before reduced-intensity transplantation improves chimerism. (Blood, 2024) [PMID:39190435]
- Development of the internal family systems model: Honoring contributions from family systems therapies. (Fam Process, 2023) [PMID:37924221]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Moving from acceptance toward transformation with Internal Family Systems Therapy (IFS). (2013) pubmed
- Emapalumab therapy for hemophagocytic lymphohistiocytosis before reduced-intensity transplantation improves chimerism. (2024) pubmed
- Development of the internal family systems model: Honoring contributions from family systems therapies. (2023) pubmed
- Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. (2004) pubmed
- Genistein. (2002) pubmed
- Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma. (2025) pubmed
- [Isoflavone-containing dietary supplements]. (2017) pubmed
- Desmoplakin CSM models unravel mechanisms regulating the binding to intermediate filaments and putative therapeutics for cardiocutaneous diseases. (2024) pubmed
- Intermediate filaments promote glioblastoma cell invasion by controlling nuclear deformations and mechanosensitive expression of MMP14. (2025) pubmed
- Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders. (2023) pubmed